AUG 11, 2026 · PHASE 1/2 TRIAL
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
ClinicalTrials.gov
This is a first-in-human Phase 1/2 trial registration with no results reported; the study is active but not yet recruiting and endpoints are not yet measured.
Reported
Estimated total enrollment240
Phase 1 planned enrollmentapproximately 42 patients
Phase 2 primary outcome measureObjective response rate (ORR) of XNW27011 a…